Medicine and Dentistry
Atrial Fibrillation
100%
Patient
71%
Antithrombotic
28%
Inpatient
27%
Apoplexy
21%
Vitamin K Antagonist
16%
Analysis
15%
Therapeutic Procedure
14%
Brain Ischemia
13%
Myocardial Infarction
11%
Care Pathway
11%
Frailty
11%
Cancer
11%
Cohort Analysis
11%
Malignant Neoplasm
11%
Diabetes
11%
Cohort Effect
11%
Arsenic
11%
Water
11%
Major Bleeding
9%
Follow up
9%
Female
6%
Age
6%
CHA2DS2-VASc Score
5%
Biochemistry, Genetics and Molecular Biology
Lipoxygenase
22%
Cohort Study
22%
Eicosapentaenoic Acid
11%
Cardiac Troponin
11%
Vitamin K
11%
Arachidonic Acid
11%
Arachidonic Acid
9%
Wild Type
8%
Single Nucleotide Polymorphism
8%
Leukotriene A4
5%
Haplotype
5%